(Q42280172)

19 October 2017

title

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

19 October 2017

main subject

0 references

author name string

Leuschner U

1

1 reference

19 October 2017

Güldütuna S

2

1 reference

19 October 2017

Imhof M

3

1 reference

19 October 2017

Hübner K

4

1 reference

19 October 2017

Benjaminov A

5

1 reference

19 October 2017

Leuschner M

6

1 reference

19 October 2017

publication date

1 October 1994

1 reference

19 October 2017

published in

Journal of Hepatology

1 reference

19 October 2017

volume

21

1 reference

19 October 2017

issue

4

1 reference

19 October 2017

page(s)

624-633

1 reference

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Daily fluctuation of cholestatic enzymes in bile and its relationship to the total bile salts concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Enzyme profiles of mammalian bile

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Bile acid-dependent secretion of alkaline phosphatase in rat bile

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

High performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by fluorescence labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Factors of prognostic importance in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

A prospective trial of D-penicillamine in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Evaluation of colchicine therapy in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Serum bilirubin: a prognostic factor in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980111-8

7 January 2021

10.1016/S0168-8278(94)80111-8

Identifiers

DOI

1 reference

19 October 2017

1 reference